Join

Join the Community

For cancer survivors and supporters!
Join

Join the Directory

For businesses & organizations that support the cancer community!
Join
Log in

cancer clinical trials in north adams, MA

A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Systemic Anaplastic Large-Cell Lymphoma, Neoplasms, Anaplastic Lymphoma Kinase, Human, NSCLC

BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab

Berkshire Hematology Oncology, P.C.-North Adams
North Adams, Massachusetts 01247

Breast Cancer

Prospective Observational Epidemiologic Study of Maraviroc's Safety

Pfizer Investigational Site
North Adams, Massachusetts 01247

Human Immunodeficiency Virus

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Kidney Neoplasms

PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Non-small Cell

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Renal Cell

A Trial In Patients With Advanced Cancer And Leukemia

Pfizer Investigational Site
North Adams, Massachusetts 01247

Neoplasms by Histologic Type

Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Cancer

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Non-Small-Cell Lung

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Non-Small-Cell Lung

A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Non Small Cell Lung Cancer

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis.

Pfizer Investigational Site
North Adams, Massachusetts 01247

Psoriasis

ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Non-Small Cell Lung Cancer (NSCLC)

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Pfizer Investigational Site
North Adams, Massachusetts 01247

Acute Lymphocytic Leukemia

A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Endometrial Neoplasms

A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Pfizer Investigational Site
North Adams, Massachusetts 01247

Acute Myeloid Leukemia

A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

Pfizer Investigational Site
North Adams, Massachusetts 01247

Acute Lymphoblastic Leukemia

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Neoplasms

Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Neoplasms

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Lung Neoplasms

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Neoplasms

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Kidney Neoplasms

Treatment With SU11248 in Patients With Neuroendocrine Tumors

Pfizer Investigational Site
North Adams, Massachusetts 01247

Neuroendocrine Tumors

Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Renal Cell, Kidney Neoplasms

Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme

Pfizer Investigational Site
North Adams, Massachusetts 01247

Glioblastoma

Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Neoplasms

A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy

Pfizer Investigational Site
North Adams, Massachusetts 01247

Lung Neoplasms

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms

A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)

Pfizer Investigational Site
North Adams, Massachusetts 01247

Gastrointestinal Stromal Tumor

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Pfizer Investigational Site
North Adams, Massachusetts 01247

Kidney Neoplasms

AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Neoplasms

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Renal Cell

A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Neoplasms

SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Renal Cell

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Renal Cell

A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248

Pfizer Investigational Site
North Adams, Massachusetts 01247

Gastrointestinal Neoplasm

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Pfizer Investigational Site
North Adams, Massachusetts 01247

Melanoma, Skin Neoplasms

Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.

Pfizer Investigational Site
North Adams, Massachusetts 01247

Colorectal Neoplasms

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Pfizer Investigational Site
North Adams, Massachusetts 01247

Adenocarcinoma, Neoplasms

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Renal Cell

Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor

Pfizer Investigational Site
North Adams, Massachusetts 01247

Gastrointestinal Stromal Tumors

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Pfizer Investigational Site
North Adams, Massachusetts 01247

Colorectal Neoplasms

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Adenocarcinoma

A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Neoplasms, Lymphoma, Non-Hodgkin

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Pfizer Investigational Site
North Adams, Massachusetts 01247

Osteoporosis

Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors

Pfizer Investigational Site
North Adams, Massachusetts 01247

Neoplasms

Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Non-Small-Cell Lung

Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Neoplasms

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Neoplasms

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Thyroid Neoplasms

An Investigational Study Drug, PD-0332991, Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.

Pfizer Investigational Site
North Adams, Massachusetts 01247

Lymphoma, Mantle-Cell

Expanded Access Program for Maraviroc At Multiple Centers

Pfizer Investigational Site
North Adams, Massachusetts 01247

Advanced HIV Infection

A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Islet Cell, Carcinoma, Pancreas

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Pancreatic Ductal

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Non Small Cell Lung

Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

Pfizer Investigational Site
North Adams, Massachusetts 01247

Ewing's Sarcoma Family of Tumors

Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Pfizer Investigational Site
North Adams, Massachusetts 01247

Non-Small-Cell Lung Carcinoma, Adenocarcinoma

A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors

Pfizer Investigational Site
North Adams, Massachusetts 01247

Solid Tumors

Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy

Pfizer Investigational Site
North Adams, Massachusetts 01247

Prostatic Neoplasms

A Study of PF-04217903 in Patients With Advanced Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Neoplasms

Follow-Up Study for Exubera

Pfizer Investigational Site
North Adams, Massachusetts 01247

Diabetes Mellitus

A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies

Pfizer Investigational Site
North Adams, Massachusetts 01247

Cancer

Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Advanced Breast Cancer

Rollover Protocol for Prior SU011248 Protocols

Pfizer Investigational Site
North Adams, Massachusetts 01247

Solid Tumors

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Pfizer Investigational Site
North Adams, Massachusetts 01247

Lymphoma, B-Cell

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Breast Cancer

Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors

Pfizer Investigational Site
North Adams, Massachusetts 01247

Neoplasms

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Pfizer Investigational Site
North Adams, Massachusetts 01247

Advanced Breast Cancer (Parts 1 and 2), Advanced Pancreatic Cancer (Part 1), Advanced Colorectal Cancer (Part 1), Advanced Cholangiocarcinoma (Part 1), Advanced Glioblastoma Multiforme (Part 1)

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Pfizer Investigational Site
North Adams, Massachusetts 01247

Arthritis, Rheumatoid

Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012

Pfizer Investigational Site
North Adams, Massachusetts 01247

Carcinoma, Renal Cell

A Study Of PF-04449913 Administered Alone In Select Solid Tumors

Pfizer Investigational Site
North Adams, Massachusetts 01247

Solid Tumors

CP-751,871 Treatment For Patients With Multiple Myeloma

Pfizer Investigational Site
North Adams, Massachusetts 01247

Multiple Myeloma

Join the directory